한글목차

양 및 산양두 백신 시장 규모는 최근 꾸준히 확대하고 있습니다. 2025년 604억 3,000만 달러에서 2026년에는 631억 9,000만 달러로, CAGR 4.6%로 성장이 전망되고 있습니다. 과거 성장 요인으로는 잦은 양-염소 두창 발생, 초기 백신 공급 부족, 정부 주도의 백신 접종 캠페인, 개발도상국의 가축 사육두수 증가, 기존 생백신(약독화 백신)의 채택 등을 들 수 있습니다.

양·산양두 백신 시장 규모는 향후 수년간 꾸준한 성장이 전망됩니다. 2030년에는 737억 4,000만 달러에 달하며, CAGR은 3.9%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 재조합 백신 및 DNA 기반 백신 기술의 발전, 보조제 첨가 불활화 백신에 대한 수요 증가, 예방 의료 프로그램 확대, 축산 투자 증가, 축산 바이오 보안 대책에 대한 인식 증가 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 보다 광범위한 보호를 위한 다가 백신 개발, 가축에 대한 주사용 백신 도입 증가, 재조합 백신 및 DNA 기반 백신에 대한 관심 증가, 양 및 염소 질병 예방에 대한 의식의 향상, 농촌 지역에서의 수의학 백신 접종 프로그램 확대 등이 있습니다. 프로그램 확대 등을 들 수 있습니다.

향후 수년간 가축 제품에 대한 수요 증가가 양 및 염소 수두 백신 시장 성장을 촉진할 것으로 예측됩니다. 축산물은 농업 환경에서 사육되는 가축에서 유래한 제품 및 자재를 말합니다. 이러한 수요 증가는 소득 및 인구 증가, 도시화, 건강에 대한 관심, 소비자 선호도 변화, 세계화, 무역, 경제 발전 등의 요인에 의해 촉진되고 있습니다. 양 및 염소 두창 백신은 질병 발생을 예방하고 양 및 염소의 건강과 생산성을 보장하여 가축을 보호하는 데 매우 중요합니다. 예를 들어 2024년 2월 영국 정부 기관인 환경식품농촌지역부(Defra)의 발표에 따르면 붉은 육류 생산량이 증가했으며, 특히 양고기 및 양고기 생산량이 2.9%로 가장 큰 성장세를 보였다고 합니다. 따라서 축산물에 대한 수요 증가가 양-염소 두창 백신 시장 성장을 촉진하고 있습니다.

또한 수의학 연구개발(R&D)에 대한 투자 증가도 양-염소 수두 백신 시장 성장을 가속할 것으로 예측됩니다. 수의학 분야의 R&D 투자는 정부, 민간 기관 및 단체가 백신, 치료법, 진단 툴, 질병 예방 전략 등 동물의 건강을 개선하기 위한 새로운 솔루션의 연구, 혁신 및 개발에 자금을 배분하는 것을 의미합니다. 가축 질병에 대한 대응을 위해 동물 건강 솔루션의 혁신과 개선이 요구되는 가운데, 이러한 투자는 증가하는 추세입니다. 투자 확대는 보다 효과적이고 안전한 동물용 백신 개발을 직접적으로 지원합니다. 예를 들어 2024년 5월 미국 농무부(USDA) 산하 정부 기관인 동식물위생검역국(APHIS)은 미국 가축을 위협하는 가장 심각한 질병에 대한 예방, 대비, 조기 발견 및 신속한 대응을 강화하기 위해 48개 주, 대학, 산업 단체 및 수의 진단 실험실가 주도하는 81개의 새로운 81개의 신규 프로젝트에 2,220만 달러 이상의 보조금이 지원되었습니다. 따라서 수의학 연구개발에 대한 투자 확대가 양 및 염소 수두 백신 시장 성장을 촉진하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Sheep and goat pox vaccines are specifically developed to prevent diseases caused by viruses belonging to the Capripoxvirus genus, which include sheep pox and goat pox. These vaccines play a critical role in preventing and managing outbreaks among sheep and goat populations, as both diseases can lead to significant economic losses due to high mortality rates and reduced productivity. They function by stimulating the immune system to generate antibodies against the viruses, thereby providing protection from infection.

The primary types of sheep and goat pox vaccines include live attenuated vaccines, inactivated vaccines, and others. Live attenuated vaccines use weakened forms of the virus to stimulate the immune system without causing severe illness. They are particularly effective for diseases such as sheep and goat pox where a robust immune response is necessary for effective protection. These vaccines are administered via various routes such as injectable and intranasal applications for sheep and goats.

Tariffs have influenced the sheep and goat pox vaccines market by increasing the cost of imported vaccine ingredients, adjuvants, and delivery equipment, especially in regions like asia-pacific and africa that rely on imports for advanced vaccines. This has led to higher production costs for multinational manufacturers while encouraging local production and innovation in recombinant and dna-based vaccines. Tariffs have also incentivized regional sourcing strategies and development of cost-effective vaccine solutions for broader livestock coverage.

The sheep and goat pox vaccines market research report is one of a series of new reports from The Business Research Company that provides sheep and goat pox vaccines market statistics, including sheep and goat pox vaccines industry global market size, regional shares, competitors with a sheep and goat pox vaccines market share, detailed sheep and goat pox vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the sheep and goat pox vaccines industry. This sheep and goat pox vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sheep and goat pox vaccines market size has grown steadily in recent years. It will grow from $60.43 billion in 2025 to $63.19 billion in 2026 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to frequent outbreaks of sheep and goat pox, limited availability of early vaccine options, government-led vaccination campaigns, rising livestock population in developing regions, adoption of traditional live attenuated vaccines.

The sheep and goat pox vaccines market size is expected to see steady growth in the next few years. It will grow to $73.74 billion in 2030 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to advancements in recombinant and dna-based vaccine technologies, increasing demand for adjuvanted inactivated vaccines, expansion of preventive veterinary healthcare programs, rising livestock farming investments, growing awareness of biosecurity measures in animal husbandry. Major trends in the forecast period include development of multivalent vaccines for broader protection, rising adoption of injectable vaccines in livestock, increased focus on recombinant and dna-based vaccines, growing awareness of sheep and goat disease prevention, expansion of veterinary vaccination programs in rural regions.

The rising demand for livestock products is expected to drive the growth of the sheep and goat pox vaccines market in the coming years. Livestock products include goods and materials derived from domesticated animals raised in agricultural settings. This demand is increasing due to factors such as income and population growth, urbanization, health concerns, changing consumer preferences, globalization, trade, and economic development. Sheep and goat pox vaccines are crucial for protecting livestock products by preventing disease outbreaks and ensuring the health and productivity of sheep and goat populations. For example, in February 2024, according to the Department for Environment, Food, and Rural Affairs, a UK-based government department, red meat production rose, with mutton and lamb production showing the largest increase of 2.9%. Therefore, growing demand for livestock products is driving growth in the sheep and goat pox vaccines market.

Increasing investment in veterinary research and development (R&D) is also expected to propel the growth of the sheep and goat pox vaccines market. Veterinary R&D investment refers to the allocation of financial resources by governments, private institutions, and organizations to study, innovate, and develop new solutions for improving animal health, including vaccines, treatments, diagnostic tools, and disease prevention strategies. Such investment is rising due to the growing need to innovate and improve animal health solutions in response to emerging and re-emerging livestock diseases. Enhanced investment directly supports the development of more effective and safer vaccines for animals. For instance, in May 2024, according to the Animal and Plant Health Inspection Service (APHIS), a US-based government agency, the USDA awarded over $22.2 million to 81 new projects led by 48 states, universities, industry organizations, and veterinary diagnostic laboratories to strengthen prevention, preparedness, early detection, and rapid response to the most damaging diseases threatening US livestock. Therefore, increasing investment in veterinary R&D is driving growth in the sheep and goat pox vaccines market.

Key players in the sheep and goat pox vaccines market are leveraging strategic partnerships to develop innovative vaccines. Strategic partnerships support the market by combining expertise and resources, advancing R&D, expanding market reach, and accelerating commercialization. For example, in February 2024, Hester Biosciences, an India-based biotechnology and vaccine company, launched a PPR-Goatpox combined vaccine, offering protection against both Peste des Petits Ruminants (PPR) and Goatpox in a single formulation. The combined vaccine simplifies vaccination schedules, reduces handling stress, lowers vaccination costs, and improves overall flock health. This development followed a strategic technology transfer from the Indian Council of Agricultural Research-Indian Veterinary Research Institute (ICAR-IVRI), allowing Hester to commercialize the indigenous vaccine by leveraging IVRI's research expertise alongside Hester's manufacturing and distribution capabilities, thereby enhancing preventive livestock healthcare and vaccine accessibility in endemic regions.

Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Sante Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer's Pharma Private Limited, Institute of Veterinary Biological Products

North America was the largest region in the sheep and goat pox vaccines market in 2025. The regions covered in the sheep and goat pox vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sheep and goat pox vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The sheep and goat pox vaccines market consists of sales of recombinant vaccines and subunit vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sheep And Goat Pox Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses sheep and goat pox vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sheep and goat pox vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sheep and goat pox vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Live Attenuated Vaccines; Inactivated Vaccines; Other Types
• 2) By Route Of Administration: Injectable; Intranasal
• 3) By Application: Sheep; Goat
• Subsegments:
• 1) By Live Attenuated Vaccines: Monovalent Live Attenuated Vaccines; Multivalent Live Attenuated Vaccines
• 2) By Inactivated Vaccines: Adjuvanted Inactivated Vaccines; Non-Adjuvanted Inactivated Vaccines
• 3) By Other Types: Recombinant Vaccines; DNA-Based Vaccines
• Companies Mentioned: Indian Immunologicals Ltd.; Kemin Industries; Bimeda Biologicals; Hester Biosciences Limited; Dollvet; MSD Animal Health; MCI Sante Animale; Creative Biolabs; Biovex Inc.; Advacare Pharma; Brilliant Bio Pharma Private Limited; Intervac (PVT) Ltd.; Agrinnovate India Limited; Bio-Med Pvt Limited; JOVAC; Vetal Animal Health Products; Kenya Veterinary Vaccines Production Institute; Vedall Pharma Private Limited; Farmer's Pharma Private Limited; Institute of Veterinary Biological Products
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Sheep And Goat Pox Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Sheep And Goat Pox Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Sheep And Goat Pox Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Sheep And Goat Pox Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Development Of Multivalent Vaccines For Broader Protection
  • 4.2.2 Rising Adoption Of Injectable Vaccines In Livestock
  • 4.2.3 Increased Focus On Recombinant And Dna-Based Vaccines
  • 4.2.4 Growing Awareness Of Sheep And Goat Disease Prevention
  • 4.2.5 Expansion Of Veterinary Vaccination Programs In Rural Regions

5. Sheep And Goat Pox Vaccines Market Analysis Of End Use Industries

• 5.1 Livestock Farmers
• 5.2 Veterinary Clinics
• 5.3 Government Animal Health Departments
• 5.4 Livestock Cooperatives
• 5.5 Private Veterinary Service Providers

6. Sheep And Goat Pox Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Sheep And Goat Pox Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Sheep And Goat Pox Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Sheep And Goat Pox Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Sheep And Goat Pox Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Sheep And Goat Pox Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Sheep And Goat Pox Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Sheep And Goat Pox Vaccines Market Segmentation

• 9.1. Global Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated Vaccines, Inactivated Vaccines, Other Types
• 9.2. Global Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Injectable, Intranasal
• 9.3. Global Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sheep, Goat
• 9.4. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Monovalent Live Attenuated Vaccines, Multivalent Live Attenuated Vaccines
• 9.5. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adjuvanted Inactivated Vaccines, Non-Adjuvanted Inactivated Vaccines
• 9.6. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Recombinant Vaccines, DNA-Based Vaccines

10. Sheep And Goat Pox Vaccines Market Regional And Country Analysis

• 10.1. Global Sheep And Goat Pox Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Sheep And Goat Pox Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Sheep And Goat Pox Vaccines Market

• 11.1. Asia-Pacific Sheep And Goat Pox Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Sheep And Goat Pox Vaccines Market

• 12.1. China Sheep And Goat Pox Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Sheep And Goat Pox Vaccines Market

• 13.1. India Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Sheep And Goat Pox Vaccines Market

• 14.1. Japan Sheep And Goat Pox Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Sheep And Goat Pox Vaccines Market

• 15.1. Australia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Sheep And Goat Pox Vaccines Market

• 16.1. Indonesia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Sheep And Goat Pox Vaccines Market

• 17.1. South Korea Sheep And Goat Pox Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Sheep And Goat Pox Vaccines Market

• 18.1. Taiwan Sheep And Goat Pox Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Sheep And Goat Pox Vaccines Market

• 19.1. South East Asia Sheep And Goat Pox Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Sheep And Goat Pox Vaccines Market

• 20.1. Western Europe Sheep And Goat Pox Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Sheep And Goat Pox Vaccines Market

• 21.1. UK Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Sheep And Goat Pox Vaccines Market

• 22.1. Germany Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Sheep And Goat Pox Vaccines Market

• 23.1. France Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Sheep And Goat Pox Vaccines Market

• 24.1. Italy Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Sheep And Goat Pox Vaccines Market

• 25.1. Spain Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Sheep And Goat Pox Vaccines Market

• 26.1. Eastern Europe Sheep And Goat Pox Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Sheep And Goat Pox Vaccines Market

• 27.1. Russia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Sheep And Goat Pox Vaccines Market

• 28.1. North America Sheep And Goat Pox Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Sheep And Goat Pox Vaccines Market

• 29.1. USA Sheep And Goat Pox Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Sheep And Goat Pox Vaccines Market

• 30.1. Canada Sheep And Goat Pox Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Sheep And Goat Pox Vaccines Market

• 31.1. South America Sheep And Goat Pox Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Sheep And Goat Pox Vaccines Market

• 32.1. Brazil Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Sheep And Goat Pox Vaccines Market

• 33.1. Middle East Sheep And Goat Pox Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Sheep And Goat Pox Vaccines Market

• 34.1. Africa Sheep And Goat Pox Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Sheep And Goat Pox Vaccines Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Sheep And Goat Pox Vaccines Market Regulatory and Investment Landscape

36. Sheep And Goat Pox Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Sheep And Goat Pox Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Sheep And Goat Pox Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Sheep And Goat Pox Vaccines Market Company Profiles
  • 36.3.1. Indian Immunologicals Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Kemin Industries Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Bimeda Biologicals Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Hester Biosciences Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Dollvet Overview, Products and Services, Strategy and Financial Analysis

37. Sheep And Goat Pox Vaccines Market Other Major And Innovative Companies

• MSD Animal Health, MCI Sante Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer's Pharma Private Limited, Institute of Veterinary Biological Products

38. Global Sheep And Goat Pox Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Sheep And Goat Pox Vaccines Market

40. Sheep And Goat Pox Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Sheep And Goat Pox Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Sheep And Goat Pox Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Sheep And Goat Pox Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer